Citadel Advisors - SINGULAR GENOMICS SYSTEMS IN ownership

SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 70 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SINGULAR GENOMICS SYSTEMS IN
ValueSharesWeighting
Q3 2023$27,440
-40.5%
72,022
+29.6%
0.00%
Q2 2023$46,116
+103.7%
55,562
+197.0%
0.00%
Q1 2023$22,637
+11.7%
18,708
+85.6%
0.00%
Q4 2022$20,259
-86.0%
10,079
-82.7%
0.00%
Q3 2022$145,000
+9.8%
58,275
+68.6%
0.00%
Q2 2022$132,000
-95.3%
34,558
-92.3%
0.00%
-100.0%
Q1 2022$2,830,000
+313.7%
448,485
+658.5%
0.00%
Q4 2021$684,000
-25.5%
59,126
-27.9%
0.00%
Q3 2021$918,000
-86.9%
82,018
-67.8%
0.00%
-100.0%
Q2 2021$7,009,000255,0660.00%
Other shareholders
SINGULAR GENOMICS SYSTEMS IN shareholders Q1 2022
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 3,798,926$7,635,8411.96%
Tikvah Management LLC 316,854$636,8770.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,450,871$12,966,2510.27%
Triatomic Management LP 155,411$312,3760.26%
Casdin Capital, LLC 1,345,722$2,704,9010.21%
Perceptive Advisors 3,282,275$6,597,3730.18%
Oasis Management Co Ltd. 221,729$445,6750.09%
PLATINUM INVESTMENT MANAGEMENT LTD 881,068$1,770,9470.07%
Anson Funds Management LP 169,747$341,1910.06%
Weil Company, Inc. 53,202$106,9360.05%
View complete list of SINGULAR GENOMICS SYSTEMS IN shareholders